Galza-Met Tablets 50Mg/850Mg (2 Strip = 14 Tablets)

Effective Blood Sugar Control with Combination Therapy

Galza-Met Tablets 50mg/850mg is a prescription oral antidiabetic medication formulated to help adults manage Type 2 Diabetes Mellitus (T2DM). Combining Vildagliptin and Metformin HCl in a single tablet, this dual-action therapy targets multiple pathways involved in blood glucose regulation.

Each strip contains 7 tablets, designed for convenient dosing as part of a structured diabetes management plan under medical supervision.

How Galza-Met 50mg/850mg Works

Galza-Met combines two proven antidiabetic agents that work together to improve glycemic control:

Vildagliptin – DPP-4 Inhibition

Vildagliptin inhibits the DPP-4 enzyme, leading to increased levels of incretin hormones GLP-1 and GIP. These hormones stimulate insulin release when blood glucose levels are elevated and decrease glucagon secretion, helping to maintain balanced sugar levels throughout the day.

Metformin HCl – Reduced Glucose Production

Metformin decreases glucose production in the liver by inhibiting gluconeogenesis and glycogenolysis. It also reduces intestinal glucose absorption and improves peripheral glucose uptake, enhancing insulin sensitivity.

Together, these mechanisms support both fasting and postprandial blood glucose control.

Key Benefits of Galza-Met

1. Dual-Mechanism Action

Addresses both insulin secretion and insulin resistance, providing comprehensive diabetes management.

2. Enhanced Metformin Strength

With 850mg of Metformin per tablet, this formulation delivers stronger glucose-lowering support for patients who require intensified therapy.

3. Convenient Fixed-Dose Combination

Combining Vildagliptin and Metformin in one tablet simplifies daily medication routines and may improve adherence.

4. Supports Long-Term Glycemic Stability

When used alongside proper diet and exercise, Galza-Met helps maintain stable blood sugar levels and supports overall metabolic health.

Who Should Use Galza-Met 50mg/850mg?

Galza-Met is indicated for adults with Type 2 Diabetes who:

• Are not adequately controlled on Metformin alone
• Require combination oral therapy
• Need additional support for improved glycemic outcomes

This medication is not suitable for individuals with Type 1 diabetes or those requiring insulin therapy.

Dosage and Administration

Galza-Met 50mg/850mg is typically taken twice daily, one tablet in the morning and one in the evening, with meals to reduce gastrointestinal side effects associated with Metformin.

The maximum daily dose of Vildagliptin should not exceed 100mg. Always follow your doctor’s prescription and do not adjust the dosage without medical advice.

If you miss a dose, take it as soon as possible the same day. Do not double doses. In case of suspected overdose, seek immediate medical attention.

Safety Information and Precautions

Galza-Met requires medical supervision and a valid prescription.

Do not use this medication if you:

• Are allergic to Vildagliptin or Metformin
• Have diabetic ketoacidosis or diabetic pre-coma
• Have severe kidney, liver, or heart disease
• Are breastfeeding

Patients should monitor for symptoms of low blood sugar, including dizziness, tremors, sweating, or confusion. Keep a fast-acting sugar source available.

Avoid alcohol while taking this medication, as it may increase the risk of side effects. Inform your healthcare provider about all medicines and supplements you are taking to prevent potential drug interactions.

Storage Instructions

Store Galza-Met Tablets at room temperature, away from direct sunlight, moisture, and excessive heat. Keep out of reach of children and pets.

Take Control of Your Diabetes Today

Effective diabetes management requires consistent therapy and lifestyle commitment. Galza-Met Tablets 50mg/850mg provide dual-action oral treatment designed to improve blood sugar control and support long-term health.

Consult your healthcare provider today to determine if Galza-Met is right for your diabetes management plan. Take a confident step toward better glycemic control and a healthier future.